Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript March 24, 2026
Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $0.04195.
Operator: Good morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals’ Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. [Operator Instructions]. As a reminder, today’s conference call is being recorded. Now I’d like to turn the conference over to...
